2 Under-the-Radar Pharma M&A Targets for 2018 Post author:Sam Post published:January 10, 2018 Post category:BioPharma A look at why these two biopharma companies could have targets on their backs. Source: BioSpace You Might Also Like Keryx, Norwich Pharma Mutually Terminate Manufacturing Agreement December 27, 2017 Bay Area Startup Offers a Compelling Deal to Scientists Hunting for New Drugs April 19, 2017 Why Pharma Giant AstraZeneca PLC's Market Value Gained $3.8 Billion Last Month March 6, 2017
